Allarity Therapeutics, Inc. (ALLR) income statement
ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.87+0.03 (+3.69%)
Close on Nov 18, 2026Market cap $13.87MP/E –Yield –
Allarity Therapeutics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- -3373.4%
- Net margin
- -3854.4%
- Return on equity, FY2025
- -103.8%
Financial strength
- Current ratio
- 1.11
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 59.4%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.92
- Dividend yield
- –
See a number that looks wrong?